1 résultat
IFCT-2401 SPORADIC trial: Integrating cemiplimab to sequential hypofractionated chemoradiotherapy for unfit or elderly patients with unresectable stage III non–small cell lung cancer
Auteurs / Authors
Thureau S, Raimbourg J, Pourel N, Curcio H, Wislez M, Guisier F, Martin E, Khalifa J, Amour E, Berndt C, Langlais A, Morin F, Westeel V, Cortot AB
Journal / Conference
ASCO
Année / Year
2026
PMID / session
Etude IFCT
